Doximity, Inc. (DOCS) Tops Q3 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- CoreWeave stock drops on dilution fears and debt concerns
Doximity Announces Fiscal 2026 Third Quarter Financial Results
February 5, 2026 4:01 PM ESTTotal revenues of $185.1 million, up 10% year-over-year
Net income of $61.6 million, margin of 33%
Adjusted EBITDA of $111.4 million, margin of 60%
SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 2025.
Were proud to deliver another quarter of strong profits and record engagement, said Jeff Tangney, co-founder and CEO of Doximity. Our newsfeed had more than 1 million quarterly active prescribers, our workflow... More



